John Breen

586 total citations
6 papers, 327 citations indexed

About

John Breen is a scholar working on Molecular Biology, Molecular Medicine and Pharmacology. According to data from OpenAlex, John Breen has authored 6 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Molecular Medicine and 3 papers in Pharmacology. Recurrent topics in John Breen's work include Cancer therapeutics and mechanisms (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). John Breen is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). John Breen collaborates with scholars based in United States, United Kingdom and India. John Breen's co-authors include Kevin L. Gunderson, Stewart L. Fisher, Daniel J. Kliebenstein, Patrick Brassil, Jonathan Gershenzon, Jae Hak Kim, Bolin Geng, Janelle Comita-Prevoir, Folkert Reck and John C. D’Auria and has published in prestigious journals such as The Plant Journal, Journal of Medicinal Chemistry and ACS Medicinal Chemistry Letters.

In The Last Decade

John Breen

6 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Breen United States	5	227	107	80	57	52	6	327
Carine Ganem‐Elbaz France	8	266 1.2×	103 1.0×	74 0.9×	59 1.0×	92 1.8×	8	464
Liu JiaYong China	11	207 0.9×	186 1.7×	49 0.6×	49 0.9×	38 0.7×	25	412
Bryan P. Kwan United States	7	236 1.0×	149 1.4×	76 0.9×	12 0.2×	63 1.2×	7	362
Thanh Lam Vietnam	9	158 0.7×	112 1.0×	60 0.8×	39 0.7×	46 0.9×	15	336
Takehiro Fukuzaki Japan	7	199 0.9×	181 1.7×	45 0.6×	41 0.7×	85 1.6×	7	392
C. S. V. HOUGE‐FRYDRYCH United States	12	323 1.4×	224 2.1×	29 0.4×	33 0.6×	99 1.9×	20	544
Andrew Galgoci United States	7	240 1.1×	101 0.9×	88 1.1×	23 0.4×	183 3.5×	8	463
Marcia Zweerink United States	6	213 0.9×	117 1.1×	35 0.4×	73 1.3×	99 1.9×	6	362
Dmitry Ghilarov Russia	14	345 1.5×	43 0.4×	77 1.0×	60 1.1×	123 2.4×	20	465
Elena B. Isakova Russia	11	172 0.8×	151 1.4×	34 0.4×	29 0.5×	115 2.2×	30	367

Countries citing papers authored by John Breen

Since Specialization

Citations

This map shows the geographic impact of John Breen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Breen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Breen more than expected).

Fields of papers citing papers by John Breen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Breen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Breen. The network helps show where John Breen may publish in the future.

Co-authorship network of co-authors of John Breen

This figure shows the co-authorship network connecting the top 25 collaborators of John Breen. A scholar is included among the top collaborators of John Breen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Breen. John Breen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

McKinney, David C., Fei Zhou, Charles J. Eyermann, et al.. (2015). 4,5-Disubstituted 6-Aryloxy-1,3-dihydrobenzo[c][1,2]oxaboroles Are Broad-Spectrum Serine β-Lactamase Inhibitors. ACS Infectious Diseases. 1(7). 310–316. 34 indexed citations

2.

Kawatkar, Sameer, Thomas A. Keating, N.B. Olivier, et al.. (2014). Antibacterial Inhibitors of Gram-Positive Thymidylate Kinase: Structure–Activity Relationships and Chiral Preference of a New Hydrophobic Binding Region. Journal of Medicinal Chemistry. 57(11). 4584–4597. 49 indexed citations

3.

Miller, M.D., Sharon Tentarelli, Minli Zhang, et al.. (2014). Alkylidene Oxapenem β-Lactamase Inhibitors Revisited: Potent Broad Spectrum Activity but New Stability Challenges. ACS Medicinal Chemistry Letters. 5(8). 915–920. 3 indexed citations

4.

Reck, Folkert, Richard A. Alm, Patrick Brassil, et al.. (2012). Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced pK_a: Antibacterial Agents with an Improved Safety Profile. Journal of Medicinal Chemistry. 55(15). 6916–6933. 65 indexed citations

5.

Reck, Folkert, Richard A. Alm, Patrick Brassil, et al.. (2011). Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity. Journal of Medicinal Chemistry. 54(22). 7834–7847. 86 indexed citations

6.

Kliebenstein, Daniel J., John C. D’Auria, Jae Hak Kim, et al.. (2007). Characterization of seed‐specific benzoyloxyglucosinolate mutations in Arabidopsis thaliana. The Plant Journal. 51(6). 1062–1076. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact